- Home
- TPST vs DRIO Comparison
TPST vs DRIO Comparison
Compare TPST & DRIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TPST
- DRIO
- Stock Information
- Founded
- TPST 2011
- DRIO 2011
- Country
- TPST United States
- DRIO United States
- Employees
- TPST N/A
- DRIO N/A
- Industry
- TPST Biotechnology: Pharmaceutical Preparations
- DRIO Medical/Dental Instruments
- Sector
- TPST Health Care
- DRIO Health Care
- Exchange
- TPST Nasdaq
- DRIO Nasdaq
- Market Cap
- TPST 33.0M
- DRIO 30.5M
- IPO Year
- TPST N/A
- DRIO N/A
- Fundamental
- Price
- TPST $7.54
- DRIO $0.58
- Analyst Decision
- TPST Hold
- DRIO Strong Buy
- Analyst Count
- TPST 3
- DRIO 2
- Target Price
- TPST $30.00
- DRIO $2.50
- AVG Volume (30 Days)
- TPST 94.0K
- DRIO 175.1K
- Earning Date
- TPST 08-11-2025
- DRIO 08-11-2025
- Dividend Yield
- TPST N/A
- DRIO N/A
- EPS Growth
- TPST N/A
- DRIO N/A
- EPS
- TPST N/A
- DRIO N/A
- Revenue
- TPST N/A
- DRIO $28,034,000.00
- Revenue This Year
- TPST N/A
- DRIO $20.85
- Revenue Next Year
- TPST N/A
- DRIO $17.09
- P/E Ratio
- TPST N/A
- DRIO N/A
- Revenue Growth
- TPST N/A
- DRIO 47.20
- 52 Week Low
- TPST $5.35
- DRIO $0.50
- 52 Week High
- TPST $28.34
- DRIO $1.55
- Technical
- Relative Strength Index (RSI)
- TPST 56.78
- DRIO 31.86
- Support Level
- TPST $7.13
- DRIO $0.52
- Resistance Level
- TPST $8.75
- DRIO $0.74
- Average True Range (ATR)
- TPST 0.47
- DRIO 0.05
- MACD
- TPST 0.12
- DRIO -0.02
- Stochastic Oscillator
- TPST 54.17
- DRIO 26.48
About TPST Tempest Therapeutics Inc.
Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.
About DRIO DarioHealth Corp.
DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. Its cross-functional team operates at the intersection of life sciences, behavioral science, and software technology to deliver seamlessly integrated and engaging digital therapeutics interventions. Also platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.